Home › Mga Autoimmune na Sakit › North Carolina › Durham
Pag-aaral pangklinika para sa Mga Autoimmune na Sakit sa Durham, NC
Isang pag-aaral para sa Mga Autoimmune na Sakit ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Durham. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Environmental Risk Factors for the Anti-synthetase Syndrome
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 7 mi ang layo
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Nagre-recruitPhase 3
- Duke University Hospital, Durham
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Nagre-recruitPhase 2/3
- Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
- University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill · 10 mi ang layo
Daratumumab in Primary Antiphospholipid Syndrome
Nagre-recruitPhase 1/2
- Duke University, Durham
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Nagre-recruitPhase 1
- Duke University Medical Center, Durham
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Nagre-recruitPhase 3
- Duke University Hospital, Durham
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Nagre-recruitPhase 3
- GSK Investigational Site, Durham
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Nagre-recruitPhase 1/2
- UNC Chapel Hill, Chapel Hill · 10 mi ang layo
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Nagre-recruitPhase 2/3
- Duke University, Durham
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
Nagre-recruitPhase 3
- Duke University Medical Center, Durham
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Nagre-recruitPhase 3
- Site Number - 1013, Durham
- Site Number - 1020, Chapel Hill · 10 mi ang layo
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Nagre-recruitPhase 1
- Duke University, Durham
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Nagre-recruitObservasyonal na pag-aaral
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi ang layo
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Nagre-recruitPhase 1
- Duke University Health System, Durham
Maternal Autoimmune Disease Research Alliance (MADRA) Registry
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Duke University, Durham
Pag-aaral para sa Mga Autoimmune na Sakit sa ibang lungsod
- Houston, TX21 pag-aaral
- Washington, DC19 pag-aaral
- New York City, NY19 pag-aaral
- Philadelphia, PA16 pag-aaral
- Boston, MA13 pag-aaral
- Los Angeles, CA12 pag-aaral
- Chicago, IL12 pag-aaral
- Dallas, TX9 pag-aaral
- Cleveland, OH8 pag-aaral
- Atlanta, GA8 pag-aaral
- Milwaukee, WI8 pag-aaral
- Portland, OR8 pag-aaral
Iba pang pag-aaral sa Durham
- Kanser sa Suso63 pag-aaral
- Kanser (lahat ng uri)58 pag-aaral
- Non-Small Cell Lung Cancer39 pag-aaral
- Multiple Myeloma37 pag-aaral
- Metastatic Cancer33 pag-aaral
- Acute Myeloid Leukemia33 pag-aaral
- Kanser sa Baga32 pag-aaral
- Kanser sa Prostate32 pag-aaral
- Colorectal Cancer28 pag-aaral
- Chronic Lymphocytic Leukemia27 pag-aaral
- Kanser sa Ovary27 pag-aaral
- Pagkabigo ng Puso26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.